Hrt Financial LP Mirum Pharmaceuticals, Inc. Transaction History

Hrt Financial LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$24.63 - $32.85 $716,659 - $955,836	29,097 New	29,097 $919,000
Q2 2022 Aug 12, 2022	SELL	$18.42 - $27.5 $198,457 - $296,285	-10,774 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$15.5 - $23.93 $166,997 - $257,821	10,774 New	10,774 $237,000
Q4 2021 Feb 14, 2022	SELL	$13.05 - $19.35 $140,835 - $208,825	-10,792 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$13.95 - $20.18 $184,335 - $266,658	-13,214 Reduced 55.04%	10,792 $214,000
Q2 2021 Aug 16, 2021	BUY	$15.84 - $20.6 $380,255 - $494,523	24,006 New	24,006 $415,000
Q1 2021 May 17, 2021	SELL	$16.29 - $21.92 $244,740 - $329,326	-15,024 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$15.75 - $25.45 $236,628 - $382,360	15,024 New	15,024 $262,000

190

54M

177K

167K

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.61B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.